EV/EBITDA
-20.05
+0.13+0.64%
Fri, 20 Dec 2024 21:15:57 GMT
Summary:
Apellis Pharmaceuticals EV/EBITDA is currently -20.05, with a rise of +0.13 (+0.64%) during the most recent trading day. Over the past year, it has dropped by -7.25 (-56.64%). APLS EV/EBITDA is now -458.50% below its all-time high of -3.59.APLS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APLS EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +0.6% |
| 1 m1 month | -19.3% |
| 3 m3 months | -46.9% |
| 6 m6 months | -70.2% |
| ytdytd | -43.5% |
| 1 y1 year | -56.6% |
| 5 y5 years | -176.9% |
APLS EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -16.79 | -19.4% | -21.58 | +7.1% |
| 3 m | 3 months | -12.45 | -61.0% | -21.58 | +7.1% |
| 6 m | 6 months | -11.35 | -76.7% | -21.58 | +7.1% |
| 1 y | 1 year | -11.35 | -76.7% | -21.58 | +7.1% |
| 3 y | 3 years | -3.59 | -458.5% | -21.58 | +7.1% |
| 5 y | 5 years | -3.59 | -458.5% | -21.58 | +7.1% |
| alltime | all time | -3.59 | -458.5% | -27.46 | +27.0% |
Apellis Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -20.05(+43.5%) |
| 2023 | -13.97(+63.0%) |
| 2022 | -8.57(+49.8%) |
| 2021 | -5.72(-57.1%) |
| Date | Value |
|---|---|
| 2020 | -13.34(+126.1%) |
| 2019 | -5.90(+23.7%) |
| 2018 | -4.77(-74.4%) |
| 2017 | -18.62 |
FAQ
- What is Apellis Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Apellis Pharmaceuticals?
- What is APLS EV/EBITDA year-to-date change?
- What is Apellis Pharmaceuticals EV/EBITDA year-on-year change?
What is Apellis Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of APLS is -20.05
What is the all time high EV/EBITDA for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high EV/EBITDA is -3.59
What is APLS EV/EBITDA year-to-date change?
Apellis Pharmaceuticals EV/EBITDA has changed by -6.08 (-43.52%) since the beginning of the year
What is Apellis Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, APLS EV/EBITDA has changed by -7.25 (-56.64%)